Candida parapsilosis is regularly isolated from mucosal infections such as vaginitis, from infected skin and nails, and from fungemia (1, 8, 15, 39, 43) . Typically, the more severe infections are nosocomial, although the incidence of C. parapsilosis as a nosocomial pathogen is lower than that of C. albicans. While outbreaks of C. parapsilosis have been reported in association with contaminated fluids, catheter colonization, and blood pressure monitoring devices, an obvious source for infections by this yeast species is not always discovered (12, 22, 41, 42) .
In the late 1980s, an extraordinary situation arose at the Veterans Administration Medical Center in San Antonio, Tex. For a few years, there was a high incidence of C. parapsilosis as the etiologic agent of nosocomial infections. Indeed, the incidence exceeded that of C. albicans (29) . To investigate the possibility of a single-source outbreak, we obtained isoenzyme profiles of the isolates of C. parapsilosis. The findings, some of which we previously reported briefly (16) , showed that there were genetically distinct groups of C. parapsilosis among the clinical isolates.
While reference strains, taken from the isoenzyme-defined groups, exhibited distinctive karyotypes (21) and random amplified polymorphic DNA (RAPD) profiles (19) , the DNA sequences of the 5.8S rDNA and the adjacent internally transcribed spacer region 2 (ITS2) were found to be identical in two of the groups (20) . Typically, when comparing different yeast species, ITS1 and ITS2, which lie on either side of the 5.8S rDNA, have greater sequence heterogeneity than the 5.8S rDNA itself (44) . For this reason, that region ( Fig. 1) has been of interest in phylogenetic studies of fungi. Given the substantial differences in karyotype patterns, isoenzyme profiles, and RAPD patterns associated with the different groups, this report of the identity of the ITS2 sequences was unexpected.
In the current report, we describe an isoenzyme analysis which demonstrated the presence of three distinct groups among clinical isolates identified as C. parapsilosis. Two of these groups were found among the isolates from the San Antonio outbreak. We have also expanded the sequence analysis of rDNA over that reported previously for C. parapsilosis (20) : the sequence now includes the 5.8S rDNA and both adjacent ITS regions. Finally, we discuss the relationship of organisms within the groups to Lodderomyces elongisporus (Recca et Mrak) van der Walt, which has been described as a teleomorph for organisms that resemble C. parapsilosis physiologically (38) .
MATERIALS AND METHODS
Fungi. Isolates were obtained from a variety of sources and are listed with their laboratory identifiers and the isoenzyme groups in Table 1 . The basic methods used to identify the yeast isolates were carbohydrate assimilation (API 20C kit; Analytab, Plainview, N.Y.), lack of germ tube formation in serum, and morphological analysis following growth on cornmeal agar. Assimilation of D-xylitol from broth was determined by the method of Wickerham (39) . C. albicans MCO50 and C. tropicalis MCO300 were laboratory isolates (17, 18) .
Isoenzyme analysis. Isoenzyme analysis, using native discontinuous polyacrylamide gel electrophoresis, followed procedures described previously (14, 17, 18) . Briefly, isolates were inoculated into 250-ml Erlenmeyer flasks containing 100 ml of yeast nitrogen base without amino acids, 0.1 M sucrose, and 0.03 M mannitol broth and incubated in a rotatory shaker (3 days, 28ЊC, 150 rpm). Washed yeasts were then broken with glass beads in the presence of 2.0 mM phenylmethylsulfonyl fluoride. The supernatant obtained after centrifugation at 13,000 ϫ g was the source of enzymes, and its protein content was determined by use of the Bradford assay (2).
For each enzyme activity analyzed, its abbreviation (if necessary), the Enzyme Commission number, the amount of protein loaded per gel lane, and the reference giving the formulation of the chromogenic reagent used to detect the activity are given in parentheses. The activities analyzed by using 7.5% (wt/vol) polyacrylamide gels were malate dehydrogenase (MDH; EC 1. at 33ЊC with shaking at 200 rpm. The culture was centrifuged (2,000 ϫ g, 10 min), and 200 l of the cell pellet was transferred to a 1.5-ml microcentrifuge tube.
The DNA was purified as described previously (19) . Basically, glass beads were used to break the yeasts in 200 l of extraction buffer (20 ml 8 .0) and centrifugation (13,000 ϫ g, 5 min, 25ЊC), the aqueous supernatant was further extracted with phenolchloroform-isoamyl alcohol and the nucleic acids were precipitated by addition of ethanol. The DNA was further purified by treatment of the preparation with RNase A and repeated phenol-chloroform-isoamyl alcohol extractions.
DNA primers. ITS primers, described by T. J. White and colleagues (44) , were either purchased (Genosys Biotechnologies, Inc., The Woodlands, Tex.) or synthesized on a 391B DNA synthesizer (Applied Biosystems, Foster City, Calif.) by the solid-phase phosphoramidite method. Primers ITS1 (5Ј-TCCGTAGGTG AACCTGCGC), ITS2 (5Ј-GCTGCGTTCTTCATCGATGC), ITS3 (5Ј-GCAT CGATGAAGAACGCAGC), and ITS4 (5Ј-TCCTCCGCTTATTGATATGC) were used. An additional primer (ITSA [5Ј-CGATGATTCACGAATATCTG]) was synthesized to enable the sequence of the ITS2-IT3 binding site to be obtained.
DNA sequencing. To obtain the 5.8S rDNA sequence and the surrounding ITS1 and ITS2 sequences (Fig. 1) , the rDNA was amplified by PCR. Each 100-l reaction contained 1ϫ PCR buffer; dATP, dCTP, dGTP, and dTTP at 100 mM each; and 2.5 U of Taq DNA polymerase (all in the GeneAmp PCR reagent kit; Perkin Elmer Cetus, Norwalk, Conn.) plus 40 pmol of ITS1, 40 pmol of ITS4, and approximately 100 ng of DNA prepared from C. parapsilosis MCO478, MCO441, MCO457, MCO471, MCO448, or MCO429. Amplification was carried out in a Perkin Elmer Cetus DNA Thermal Cycler with initial denaturation for 3 min at 95ЊC, followed by 30 cycles of 0.5 min at 95ЊC, 1.5 min at 55ЊC, 2 min at 72ЊC, and a final extension for 10 min at 72ЊC. After amplification, the DNA was resolved by electrophoresis in a 1% agarose gel, stained with ethidium bromide, and further purified with a Qiaex gel extraction kit (Qiagen, Chatsworth, Calif.).
Direct sequencing of the PCR products, by application of the dideoxynucleotide method with a radiolabeled primer, was done as described previously with little modification (32, 37) . Sequencing primers ITS1, ITS2, ITS3, ITS4, and ITSA were end labeled with [␥-32 P]ATP by using T4 polynucleotide kinase (Pharmacia-LKB, Piscataway, N.J.) and then added to 20 ng of the heat-denatured, PCR-amplified DNA. After time was allowed for annealing (4ЊC, 5 min), the mixture was divided into four tubes, each containing 3 l of 80 mM deoxyribonucleoside triphosphates and a single dideoxyribonucleoside triphosphate at 8 mM. Sequenase (1.5 U of a modified form of T7 DNA polymerase; United States Biochemical, Cleveland, Ohio) was added to each tube. After incubation (5 min, 37ЊC), the samples were heated (95ЊC, 5 min) and electrophoresed on an 8% (wt/vol) denaturing polyacrylamide gel. The gel was dried and exposed to X-ray film (X-OMAT; Kodak, Rochester, N.Y.), and the DNA sequence was determined after the film had been developed.
Proteinase detection. Secretion of proteinase by C. parapsilosis on bovine serum albumin (BSA) agar was tested by using a semiquantitative screening procedure similar to that described by Rüchel and colleagues (31) . Each 100 ml of BSA agar contained 1.17 g of yeast carbon base (Difco), 10 mg of yeast extract (Difco), 200 mg of bovine albumin (fraction V; Miles, Kankakee, Ill.), and 2.0 g of agar (Difco). The medium, lacking the agar, was prepared as a concentrate, adjusted to pH 5.0, sterilized by filtration through a cellulose acetate membrane (0.45-m pore size), and then added to autoclaved agar solution held at 55ЊC. Plates were poured immediately after mixing. Before preparation of yeast inocula, each strain was cultivated on a Sabouraud dextrose agar plate at 28ЊC for 24 h. Colonies were then resuspended in sterile distilled water to a turbidity equivalent to a 0.5 McFarland standard. Five-microliter yeast suspension samples were inoculated onto BSA agar plates, and the cultures were incubated at room temperature for 10 days. The proteolysis of BSA was visualized after staining with 0.1% naphthol blue black (Sigma) in 3.5 M acetic acid and differentiation in 1.2 M acetic acid. Proteinase activity was scored as follows (7): Ϫ, no visible clarification of the agar around the colonies; Ϯ, very limited clarification of the agar under or around the colonies; 1ϩ, clearly visible proteolysis beyond the fringe of the colonies; 2ϩ, proteolysis largely Ͼ2 mm from the margin of the colonies.
Antifungal susceptibility testing. Antifungal susceptibility testing was done by a macrodilution method described by Fromtling et al. (11) , with minor modifications. Yeasts were cultured on Sabouraud agar (24 h, 35ЊC) and then suspended in sterile water. The suspension was adjusted by visual comparison to a 0.5 McFarland barium sulfate standard and then diluted 1:2,000 with RPMI 1640 (Gibco Laboratories, Grand Island, N.Y.) which had been buffered at pH 7.0 with 100 mM morpholinepropanesulfonic acid (MOPS; Sigma). A 0.9-ml inoculum was added to a glass tube (12 by 75 mm) containing a 0.1-ml volume of a solution of the antifungal drug amphotericin B, ketoconazole, or 5-fluorocytosine (all from Sigma). Final drug concentrations ranged from 0.002 to 8.0 g/ml, and the tubes were incubated without shaking at 30ЊC for 48 h. The lowest concentration of an antifungal agent associated with no visible growth in a tube was taken as representing the MIC.
Nucleotide sequence accession numbers. The sequences for the groups of C. parapsilosis were submitted to GenBank. The accession numbers are as follows: group I (MCO478 and MCO441), U10987; group II (MCO457 and MCO471), U10988; group III (MCO448 and MCO429), U10989.
RESULTS
Isoenzyme comparison. Isoenzyme analysis showed the presence of three distinct groups among the clinical C. parapsilosis isolates. For several enzymes, the patterns for the groups were clearly distinct (Fig. 2) . For instance, the patterns of EST, SOD, and glucose 6-phosphate dehydrogenase differentiated the three groups. In other cases, enzyme patterns overlapped. However, the pattern of MDH distinguished group I, the pattern of catalase distinguished group III, and the patterns of acid phosphatase and ␤-glucosidase distinguished group II. Although there was some variation in some enzyme patterns within a group, a finding that is typical with isoenzymes, when any two isolates were compared, most of the enzymatic activities showed identical patterns. Variation seen within a group can be observed in Fig. 2 ; for example, EST patterns differed within group II and the more slowly migrating, cyanide-insensitive SOD showed heterogeneity within group I.
Like the isoenzyme profiles of C. albicans MCO50 and C. tropicalis MCO300, the profile of L. elongisporus did not closely resemble any of the three C. parapsilosis groups; indeed, most of the enzyme activities showed different patterns (Fig. 3) . L. elongisporus had more slowly migrating catalase and SOD, a distinct EST pattern, strong mannitol dehydrogenase activity, and weak ␣-glucosidase activity. However, an occasional enzyme pattern did not distinguish L. elongisporus from C. parapsilosis. For example, L. elongisporus glucose 6-phosphate dehydrogenase resembled that of C. parapsilosis group II and its MDH migrated only very slightly more slowly than the MDH of C. parapsilosis groups II and III. Such interspecies similarities were also detected in some cases with C. albicans and C. tropicalis, where patterns similar to those of some C. parapsilosis isolates were seen for ␣-glucosidase, MDH, and catalase. Examples are shown in Fig. 3 (MDH, lanes 1 and 6; EST, lanes 2 and 8; ␣-glucosidase, lanes 1 and 5, 6, 9, and 10 or lanes 2 and 8).
Because of changes in apparatus and reagents, some of the band intensities differ when the same activities are compared in Fig. 2 and 3 . These differences did not alter the conclusion that there are distinct groups of C. parapsilosis.
Sequence analysis. The C. parapsilosis rDNA was sequenced for six strains by using two strains for each isoenzyme-defined group (Fig. 4) . The strains used for group I were from different sources and had differing SOD patterns; similarly, the two group II isolates were selected because they showed distinct EST patterns and were unlikely to represent the same clone.
Both strains from within the same group had identical sequences. In contrast, there were substantial differences between the groups with sequence similarities ranging from 82 to 88% (Table 2 ). Most differences were observed in ITS1, while the 5.8S rDNA regions were identical and ITS2 showed minimal differences, with similarity between groups of about 96%. Far greater dissimilarity was observed in all regions of the rDNA when the sequences were compared to that reported for C. albicans (20, 23) . The 5.8S rDNA sequence of C. parapsilosis groups I and II reported by Lott et al. (20) was identical to the sequence we determined, but we found differences within ITS2. In contrast Fig. 1 . b (Number of matched bases in both sequences/total number of bases in both sequences) ϫ 100%.
c Total sequence (ITS1, 5.8S rDNA, and ITS2). This is shown in Fig. 4 . to the current sequence, as numbered in Fig. 4 , Lott et al. reported a cytosine at position 328, a guanosine following position 351, no thymine at position 397, and an adenine at position 436. In addition, those researchers did not note the absence of a cytosine residue at position 429 in the group II sequence. These minimally discordant data are unlikely to be due to sequencing errors introduced during the manual sequencing done for the current study. This is because we obtained the same ITS2 sequence for both strains within each group.
Phenotypic differences between groups. The API 20C-defined biotypes are listed in Table 1 . There was a single metabolic difference which correlated with the isoenzyme-defined groups. This was the lack of D-xylitol assimilation in groups I and II versus the positive result for its assimilation in group III. This result is shown by a score of 5 versus 7 in the third position of the biotype score. In contrast to the results obtained with the API 20C kit, all groups assimilated xylitol from broth.
L. elongisporus differed from the C. parapsilosis groups in its API 20C biotype score. Only extremely weak assimilation was detected for L-arabinose or D-xylose, and these were scored as being negative. This resulted in a score of 1 as the second number in the biotype (Table 1) .
Thirty-eight C. parapsilosis strains, 26 group I strains and all of the group II and III strains, were tested for extracellular proteinase production. Nineteen group I strains showed strong proteolytic activity with scores of 1ϩ and 2ϩ ( Fig. 5 ; Table 1 ). In contrast, none of the group II and III strains had strong proteinase activity: indeed, 6 of the 10 group II strains and both group III strains failed to show detectable activity within the 10-day incubation time. After a subset of cultures had been incubated for 45 days, proteolysis was observable for the weakly reactive group I and II isolates but neither group III strain produced significant proteolytic activity (data not shown).
The results obtained with the same panel of 38 yeast isolates showed substantial overlaps in the antifungal susceptibilities of isolates representing the three groups of C. parapsilosis (Fig.  6) . The only significant difference between the groups was in the comparison of group I and II susceptibilities to 5-fluorocytosine. This difference was based on the number of isolates that were unable to grow at each drug concentration (MannWhitney U test, two tailed; z ϭ Ϫ2.246, P Ͻ 0.025). The difference in the group I and II distributions for 5-fluorocytosine susceptibility was confirmed by using 2 analysis (P ϭ 0.033).
DISCUSSION
The presence of three distinct isoenzyme-defined groups among the isolates of C. parapsilosis from clinical specimens demonstrated that there is profound genetic heterogeneity within C. parapsilosis even though its three groups have very similar API 20C biotypes. Heterogeneity within this species has been reported previously for some of the same strains, and those results showed that representative organisms in the different groups were characterized by very different karyotypes and RAPD profiles (19, 21) . The fact that isoenzyme analysis correlates well with other genetic markers, including rDNA sequencing, is not surprising. The correlation has been elegantly shown for RAPD patterns used in grouping parasitic protozoa (36) and in typing diarrhea-causing Escherichia coli (40) . This is not the first time genetic heterogeneity has been reported for C. parapsilosis. Sometimes, the apparent heterogeneity is the result of a misidentification, a continuing problem that we have noted when receiving panels of organisms for investigation by the isoenzyme technique. Such misidentified organisms have the potential to confuse interpretations of work reported by others. Scherer and Stevens reported on three major patterns for the fragments produced after digestion of whole-cell DNA with restriction endonuclease EcoRI (33) . Others have observed fairly large differences among karyotypes and in DNA fingerprints (3, 5) . The latter were produced by digesting chromosomes with rarely cutting endonucleases and subsequent separation of the fragments by pulsed-field agarose electrophoresis. The strains described in the examples cited above differ from those we have studied, and we do not know which groups they represent. Similarly, we have not examined the two strains named C. parapsilosis that were described as having distinct protein and isoenzyme patterns (34) . One of these strains, NCYC 548, is identified in the American Type Culture Collection as Kluyveromyces drosophilarum.
Together with the distinct rDNA sequences that are reported here, the many genetic differences demonstrate that somewhat distantly related organisms are included in the single taxon C. parapsilosis. It was interesting that the rDNA sequence heterogeneity was largely confined to ITS1, and this shows that screening of the ITS2 and 5.8S rDNA sequences for species differences, as was done for a number of Candida DNA homology studies should establish whether the betweengroup sequence differences (Fig. 4 and Table 2 ), which are not as great as the differences typically reported for different Candida species (20) , signify distinct yeast species. Similarly, such data would be helpful in interpreting the significance of the differing karyotype patterns (21), RAPD patterns (19) , and isoenzyme profiles in predicting the presence of distinct yeast species rather than variants. There was little isoenzyme pattern heterogeneity among isolates of C. parapsilosis group I (data not shown). This contrasted with the patterns found for the other two isoenzyme groups of C. parapsilosis and for C. albicans (6, 18 ). An unusual stability in the C. parapsilosis mitochondrial DNA has also been reported (4, 35) , and we do not know the reason for the stability in genetic structure that characterizes C. parapsilosis group I. This is the group which we have found both here and in other studies on, for example, nail disease (30) to be the predominant group among clinical isolates. Possibly, C. parapsilosis occupies a highly stable environmental niche (13) .
It is clear that isoenzyme testing is not a promising approach to typing C. parapsilosis group I for epidemiological purposes. Other methods, such as RAPD patterns or pulsed-field gel electrophoretic procedures, seem more likely to be profitable, but even here, the strain-to-strain variations seem far smaller than those associated with C. albicans (19) . However, in the context of the San Antonio outbreak, the isoenzyme patterns showed the outbreak isolates to be composed of several group I and II strains. Therefore, the spread of a single virulent strain can be excluded as a cause of the outbreak. Analysis of the outbreak by DNA fingerprinting points to a similar conclusion (28) .
The isoenzyme profiles excluded the possibility that any of the clinical isolates were anamorphic forms of L. elongisporus, a species originally reported to be the teleomorph of C. parapsilosis (38) . Previously, L. elongisporus had been shown to differ in several ways from the type strain of C. parapsilosis, which belongs to group I. The differences were defined by DNA-DNA reassociation kinetics, serology, physiology, mannan structure determined by proton magnetic resonance spectroscopy, isoenzyme patterns, and cytochrome spectra measured at Ϫ196ЊC (25) (26) (27) 45) . A number of other possible relationships need to be studied, such as the relationship of groups II and III to C. parapsilosis var. querci. This is a yeast that has been found to be associated with materials produced by insects that attack oak trees and with marine sources; it appears to be genetically distinct from the type strain (4, 26) . However, it is not unreasonable to expect that groups II and III represent unnamed organisms having significant genetic dissimilarity from the type strain of C. parapsilosis.
The clinical significance of the groups is not clear. Secretion of extracellular proteinase has been suggested to be one of the important factors associated with pathogenicity of C. parapsilosis, for strongly proteolytic isolates have been isolated from women with vaginitis (8, 9) . Therefore, it was interesting to find that the three groups were characterized by differences in proteinase activity with the majority of group I isolates being either moderately strong or strong proteinase producers. However, many more clinical isolates from groups II and III should be examined to confirm the characteristic of low proteinase activity before proteinase assays are used to screen populations of C. parapsilosis to enrich for groups II and III. It would be particularly useful to obtain further isolates from group III, as only two are currently available.
In contrast to the findings on proteinase production, the groups showed overlapping profiles for antifungal susceptibility. The tendency to show increased resistance to 5-fluorocytosine among the group II isolates, while significant, is not dramatic, and it is unlikely to be a major concern when considering therapeutic use of the drug. However, this differential susceptibility might provide a useful way of enriching for group II when screening large numbers of C. parapsilosis isolates. While both group III isolates had the same susceptibility to antifungal agents; they may not be fully representative of the group and more isolates should be examined.
For those wishing to recognize the groups, the rDNA sequence should allow establishment of the group of a novel isolate. More conveniently, the differences in isoenzymes, especially SOD, EST, and glucose 6-phosphate dehydrogenase, as well as differences in RAPD patterns and electrophoretic karyotypes, allow differentiation of the three groups. The patterns may be best determined in comparison to reference isolates in the American Type Culture Collection ( Table 1) .
The presence of three groups should be considered in both epidemiological and diagnostic studies, as well as in basic studies on the pathogenicity of C. parapsilosis.
